These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8200078)
41. The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase. Stiborová M; Dracínská H; Hájková J; Kaderábková P; Frei E; Schmeiser HH; Soucek P; Phillips DH; Arlt VM Drug Metab Dispos; 2006 Aug; 34(8):1398-405. PubMed ID: 16714372 [TBL] [Abstract][Full Text] [Related]
42. Effects of inhibition of hepatic sulfotransferase activity on renal genotoxicity induced by lucidin-3-O-primeveroside. Ishii Y; Kijima A; Takasu S; Ogawa K; Umemura T J Appl Toxicol; 2019 Apr; 39(4):650-657. PubMed ID: 30874336 [TBL] [Abstract][Full Text] [Related]
43. Sex differences in the formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice. Zu HX; Schut HA Carcinogenesis; 1991 Nov; 12(11):2163-8. PubMed ID: 1934305 [TBL] [Abstract][Full Text] [Related]
44. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene. Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033 [TBL] [Abstract][Full Text] [Related]
45. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen. Pathak DN; Pongracz K; Bodell WJ Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496 [TBL] [Abstract][Full Text] [Related]
46. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
47. Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver. Gupta KP; van Golen KL; Putman KL; Randerath K Carcinogenesis; 1993 Aug; 14(8):1517-21. PubMed ID: 8102595 [TBL] [Abstract][Full Text] [Related]
48. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers. Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924 [TBL] [Abstract][Full Text] [Related]
49. Effect of tamoxifen feeding on metabolic activation of tamoxifen by the liver of the rhesus monkey: does liver accumulation of inhibitory metabolites protect from tamoxifen-dependent genotoxicity and cancer? Comoglio A; Gibbs AH; White IN; Gant T; Martin EA; Smith LL; Gamalero SR; DeMatteis F Carcinogenesis; 1996 Aug; 17(8):1687-93. PubMed ID: 8761427 [TBL] [Abstract][Full Text] [Related]
50. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624 [TBL] [Abstract][Full Text] [Related]
51. Formation and removal of pentachlorophenol-derived protein adducts in rodent liver under acute, multiple, and chronic dosing regimens. Tsai CH; Lin PH; Troester MA; Rappaport SM Toxicol Sci; 2003 May; 73(1):26-35. PubMed ID: 12700421 [TBL] [Abstract][Full Text] [Related]
52. Hepatocyte metabolism of coenzyme Q1 (ubiquinone-5) to its sulfate conjugate decreases its antioxidant activity. Chan TS; O'Brien PJ Biofactors; 2003; 18(1-4):207-18. PubMed ID: 14695936 [TBL] [Abstract][Full Text] [Related]
53. Inhibition by pentachlorophenol of the initiating and promoting activities of 1'-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver. Boberg EW; Liem A; Miller EC; Miller JA Carcinogenesis; 1987 Apr; 8(4):531-9. PubMed ID: 2881629 [TBL] [Abstract][Full Text] [Related]
54. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. Jeurissen SM; Punt A; Delatour T; Rietjens IM Food Chem Toxicol; 2008 Jun; 46(6):2296-302. PubMed ID: 18433972 [TBL] [Abstract][Full Text] [Related]
55. A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism. Potter GA; McCague R; Jarman M Carcinogenesis; 1994 Mar; 15(3):439-42. PubMed ID: 8118925 [TBL] [Abstract][Full Text] [Related]
57. Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen. Phillips DH; Potter GA; Horton MN; Hewer A; Crofton-Sleigh C; Jarman M; Venitt S Carcinogenesis; 1994 Aug; 15(8):1487-92. PubMed ID: 8055624 [TBL] [Abstract][Full Text] [Related]
58. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927 [TBL] [Abstract][Full Text] [Related]
59. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans. Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate. Meerman JH; van Doorn AB; Mulder GJ Cancer Res; 1980 Oct; 40(10):3772-9. PubMed ID: 6159969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]